Neogenomics, Inc.
NEO
$10.10
$0.323.27%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 10.10% | 9.70% | 10.10% | 11.65% | 12.06% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.10% | 9.70% | 10.10% | 11.65% | 12.06% |
| Cost of Revenue | 10.36% | 7.37% | 5.37% | 6.75% | 6.67% |
| Gross Profit | 9.76% | 12.83% | 16.70% | 18.60% | 19.92% |
| SG&A Expenses | 10.53% | 8.41% | 5.73% | 6.94% | 3.71% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.77% | 8.53% | 6.20% | 7.13% | 5.54% |
| Operating Income | -16.32% | 0.06% | 19.09% | 20.59% | 28.75% |
| Income Before Tax | -42.79% | -26.39% | 13.63% | 16.91% | 25.62% |
| Income Tax Expenses | 75.20% | 71.12% | 84.42% | 78.65% | 80.87% |
| Earnings from Continuing Operations | -45.98% | -32.46% | 7.89% | 10.51% | 19.31% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -45.98% | -32.46% | 7.89% | 10.51% | 19.31% |
| EBIT | -16.32% | 0.06% | 19.09% | 20.59% | 28.75% |
| EBITDA | -308.83% | -12.77% | 80.07% | 83.11% | 86.15% |
| EPS Basic | -44.27% | -30.91% | 8.79% | 11.33% | 20.05% |
| Normalized Basic EPS | -26.51% | -1.83% | 20.92% | 24.73% | 35.87% |
| EPS Diluted | -43.55% | -29.92% | 8.70% | 11.70% | 20.31% |
| Normalized Diluted EPS | -26.51% | -1.83% | 20.92% | 24.73% | 35.87% |
| Average Basic Shares Outstanding | 1.09% | 1.05% | 0.96% | 0.92% | 0.92% |
| Average Diluted Shares Outstanding | 1.09% | 1.05% | 0.96% | 0.92% | 0.92% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |